A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure

BACKGROUND: The Swiss label of oral fingolimod (0.5 mg once daily) requires a 6-hour first dose observation (FDO) including an ECG prior to and 6 hours after the first intake but in comparison to other countries such as Austria, Australia and Canada there are no restrictions regarding the clinical s...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramseier, Simon P, Roth, Serge, Czaplinski, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405834/
https://www.ncbi.nlm.nih.gov/pubmed/25889400
http://dx.doi.org/10.1186/s40360-015-0006-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405834/
https://www.ncbi.nlm.nih.gov/pubmed/25889400
http://dx.doi.org/10.1186/s40360-015-0006-0

Ejemplares similares